Squarepoint
CGNT

Squarepoint’s Cogentix Medical, Inc. CGNT Stock Holding History

Squarepoint’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,800
Closed -$23K – 1994
2017
Q1 		$23K Buy
+12,800
New +$25.3K ﹤0.01% 1473

Other funds holding CGNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Squarepoint's CGNT Position: Q2 2017 in Review

Squarepoint sold out of Cogentix Medical, Inc. (CGNT) in Q2 2017, closing a stake of 12,800 shares — an estimated $23K sold.

Squarepoint first reported a position in CGNT in Q1 2017 and held it in 1 quarter. The position peaked at $23K in Q1 2017. 34 funds tracked by Wall St. Rank hold CGNT as of Q2 2017.

  • Squarepoint reported no remaining Cogentix Medical, Inc. position as of Q2 2017 after selling out during the quarter.
  • Squarepoint sold 12,800 Cogentix Medical, Inc. shares in Q2 2017, an estimated $23K.
  • Squarepoint first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 1 quarter.
  • Squarepoint's Cogentix Medical, Inc. position peaked at $23K in Q1 2017.
  • 34 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2017.

Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.